BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 18, 2017
View Archived Issues
Blockade of G-CSF receptor found to improve arthritic pain in mice
Read More
NIH grant supports UIC evaluation of TAT-PTEN9c to improve survival post heart attack
Read More
Transcription elongation factors as novel therapeutic targets in glioblastoma
Read More
Axsome initiates phase II/III trial of AXS-05 for Alzheimer's disease agitation
Read More
Novartis has 5-year data for Cosentyx in plaque psoriasis
Read More
Rv3723/LucA as a promising new target for Mycobacterium tuberculosis infection
Read More
Wave begins PRECISION-HD program for WVE-120101 and WVE-120102 in Huntington's disease
Read More
Proellex to remain on partial clinical hold
Read More
CymaBay reports promising interim phase II data on seladelpar in primary biliary cholangitis
Read More
FDA grants priority review to voretigene neparvovec BLA
Read More
REDX-05194 ameliorates diabetic nephropathy in mice by reducing inflammasome activation
Read More
FDA approves Nerlynx as extended adjuvant therapy for early stage HER2-positive breast cancer
Read More
NICE final guidance recommends Humira, Enbrel and Stelara for plaque psoriasis in children
Read More
Julius-Maximilians-Universitaet Wuerzburg divulges polypeptides for thrombotic disorders
Read More
Paratek reports promising topline phase III data for omadacycline in ABSSSI
Read More
Flatley Discovery Lab identifies CFTR channel correctors
Read More
Chugai Pharmaceutical presents antibodies for treating muscle wasting
Read More
Norgine completes Merus acquisition
Read More
Ligand grants Amgen commercial rights to use Captisol technology in formulation of AMG-330
Read More
New phase II trial investigates CPP-1X in patients at high risk of gastric cancer
Read More
CStone cleared to begin clinical trials of CS-1001 in China
Read More
New murine model of celiac disease developed
Read More
